Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature

Autor: Grob, Jean-Jacques, Mortier, Laurent, D’Hondt, Lionel, Grange, Florent, Baurain, JeanFrancois, Dréno, Brigitte, Lebbe, Céleste, Robert, Caroline, Dompmartin, Anne, Neyns, Bart, Gillet, Marc, Louahed, Jamila, Jarnjak, Silvija, Lehmann, Frédéric F.
Zdroj: In ESMO Open 2017 2(5)
Databáze: ScienceDirect